E/M Coding Alert - 2005 Issue 44
PHARMACEUTICALS: Senator Takes Shot At New CMS Drug Web Site
Subscribe or sign in to view the full article.
Article Overview
This article discusses concerns raised about a new CMS online drug plan comparison tool for Medicare beneficiaries. It covers criticism from a senator and a senior-citizens advocacy group, CMS’s acknowledgement of incomplete initial data, and the broader effort to help beneficiaries compare plans and understand enrollment-related resources.
Why This Topic Matters
It helps readers understand why the new Medicare drug plan website was drawing scrutiny and how CMS was presenting the tool during its rollout. The piece is relevant to professionals and stakeholders following Medicare Part D beneficiary support, outreach, and plan-comparison resources.
What You Will Learn
- What the article says about early concerns with CMS’s new Medicare drug plan website
- Which organizations and stakeholders responded to the tool’s launch
- What broad types of information the article says beneficiaries expected from the site
- How CMS described the rollout context and related outreach efforts
Who Should Read This
- Medical coders and billing staff
- Healthcare administrators
- Medicare and health policy professionals
- Pharmacy and pharmaceutical industry readers
- Beneficiary advocacy and outreach staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com